STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Sotera Health Company SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Sculptor Capital and affiliated entities report collective beneficial ownership of 14,750,000 common shares of Sotera Health Company, representing 5.19% of the outstanding class based on 284,046,606 shares. The stake is held across multiple related reporting persons (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. and Sculptor Master Fund, Ltd.), each reporting shared voting and dispositive power of 14,750,000 shares and no sole voting or dispositive power. The filing states these shares are held in accounts managed by Sculptor and Sculptor-II and calculates percentages using the issuer’s 424B7 disclosed share count. The filing includes certifications that the position was not acquired to change or influence control of the issuer.

Positive
  • Clear disclosure of a >5% position (14,750,000 shares, 5.19%) by Sculptor and affiliates
  • Consolidated reporting across related entities clarifies ownership and control relationships
  • Filing classified as Schedule 13G, indicating the position is represented as passive rather than an attempt to influence control
Negative
  • None.

Insights

TL;DR: A Delaware-based investment manager group reports a >5% passive stake in Sotera Health, disclosed under Schedule 13G.

The filing shows Sculptor and affiliated entities collectively hold 14.75 million shares, or 5.19% of Sotera Health, with shared voting and dispositive power across the reporting entities and no sole control. This is reported on a Schedule 13G, indicating the filer contends the position is passive and not intended to influence control. The ownership percentage is calculated using 284,046,606 outstanding shares per the issuer’s 424B7. For investors, a >5% passive stake signals a significant shareholder position that may be monitored for any future change in intent or transition to an active filing.

TL;DR: Multiple related entities disclosed coordinated beneficial ownership, consistent with common fund/advisory structures.

The schedule identifies a group of related Sculptor entities that may be deemed beneficial owners under SEC rules due to management and ownership relationships. All reporting persons declare shared voting and dispositive authority for the full stake, and the filing includes the required certification that the holdings are not for the purpose of changing control. The structure and cross-references to parent and general partner relationships are clearly disclosed, aiding transparency for governance and regulatory review.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital LP ("Sculptor"), a Delaware limited partnership, is the principal investment manager to a number of private funds and discretionary accounts (collectively, the "Accounts").


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital II LP ("Sculptor-II"), a Delaware limited partnership that is wholly owned by Sculptor, also serves as the investment manager to certain of the Accounts. The Ordinary Shares reported in this Schedule 13G are held in the Account(s) managed by Sculptor and Sculptor-II.


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital Holding Corporation ("SCHC"), a Delaware corporation, serves as the general partner of Sculptor.


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital Holding II LLC ("SCHC-II"), a Delaware limited liability company that is wholly owned by Sculptor, serves as the general partner of Sculptor-II.


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Capital Management, Inc. ("SCU"), a Delaware limited liability company, is a holding company that is the sole shareholder of SCHC and the ultimate parent company of Sculptor and Sculptor-II.


SCHEDULE 13G




Comment for Type of Reporting Person: Sculptor Master Fund, Ltd. ("SCMF") is a Cayman Islands company. Sculptor is the investment adviser to SCMF.


SCHEDULE 13G



Sculptor Capital LP
Signature:/s/ Wayne Cohen
Name/Title:Wayne Cohen / President and Chief Operating Officer
Date:09/11/2025
Sculptor Capital II LP
Signature:/s/ Wayne Cohen
Name/Title:Wayne Cohen / President and Chief Operating Officer
Date:09/11/2025
Sculptor Capital Holding Corp
Signature:/s/ Wayne Cohen
Name/Title:Wayne Cohen / President and Chief Operating Officer
Date:09/11/2025
Sculptor Capital Holding II LLC
Signature:/s/ Wayne Cohen
Name/Title:Wayne Cohen / Chief Financial Officer
Date:09/11/2025
Sculptor Capital Management, Inc.
Signature:/s/ Wayne Cohen
Name/Title:Wayne Cohen / President and Chief Operating Officer
Date:09/11/2025
Sculptor Master Fund, Ltd.
Signature:/s/ Wayne Cohen
Name/Title:Wayne Cohen / President and Chief Operating Officer
Date:09/11/2025

FAQ

How many Sotera Health (SHC) shares does Sculptor report owning?

Sculptor and affiliated entities report beneficial ownership of 14,750,000 shares of Sotera Health common stock.

What percentage of SHC does the 14,750,000-share stake represent?

The filing states the position represents 5.19% of the outstanding common shares, based on 284,046,606 shares outstanding.

Do any Sculptor entities claim sole voting or dispositive power over the SHC shares?

No. The filing reports 0 sole voting power and 0 sole dispositive power; all 14,750,000 shares are reported with shared voting and dispositive power.

Which Sculptor entities are named in the Schedule 13G for SHC?

The filing names Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., and Sculptor Master Fund, Ltd.

Was the stake reported on a Schedule 13G or 13D and what does that imply?

It was reported on a Schedule 13G, which the filers use to indicate the position is passive and not intended to change or influence control of the issuer.
Sotera Health Co

NASDAQ:SHC

SHC Rankings

SHC Latest News

SHC Latest SEC Filings

SHC Stock Data

4.72B
174.03M
2.46%
89.45%
3.99%
Diagnostics & Research
Services-misc Health & Allied Services, Nec
Link
United States
BROADVIEW HEIGHTS